Trinity Bio ADR (TRIB) Stock Price, Quote & News

Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles,...

Industry: Medical Devices

Sector: Healthcare

Phone: 353 1 276 9800

Fax: 353 1 276 9888

Website: www.trinitybiotech.com

Address:

IDA Business Park, Bray, Ireland

God_Damnit Jul. 6 at 9:23 PM

$PMAX I would have to say this is my favorite stock coming into Monday It's almost trending too 10 on webull and certainly is number 1 on Stocktwits $WKSP and $UPXI closed over 10% up I'm watching $BREA and $TRIB too

0 · Reply

GuineaPigForever Jul. 3 at 10:49 AM

$TRIB wow, 75% of the volume yesterday was shorting. Could have been brokers filling orders with no shares to do it with. Liquidity problems in this one (obvious by the crazy spreads). IMO its a time bomb.

1 · Reply

GuineaPigForever Jul. 2 at 8:05 PM

$TRIB short volume (not to be confused by short interest) was over 50% the last couple of days and likely today too. Over half of all trades were shorting.

0 · Reply

GuineaPigForever Jul. 2 at 7:49 PM

$TRIB yep, par for the coarse for a bio stock after a couple rounds of good news. Nothing fishy here.

0 · Reply

GuineaPigForever Jul. 2 at 2:48 PM

$TRIB looks like they borrowed over 40,000 shares just a few minutes ago. Wonder why they see a short position is wise here?

0 · Reply

RollingDollars Jul. 2 at 9:42 AM

$TRIB

0 · Reply

Benamin38659 Jul. 2 at 8:49 AM

$TRIB quarter revenue of 7.6 million.

0 · Reply

Super5Investments Jul. 2 at 2:20 AM

$TRIB Investment community hates this stock. Its a natural born loser.Even good news like profitability cant move it.

0 · Reply

hardrock2112 Jul. 1 at 1:19 PM

$TRIB DUBLIN , July 01, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), ... believes it has reached a critical profitability inflection point during the latter part of the current financial quarter, a key milestone in its comprehensive transformation strategy. The Company now expects to be meaningfully Adjusted EBITDA1 -positive and to be cash flow positive from its ongoing operating activities starting Q3 2025 and into the foreseeable future. In addition, the Company today also released details regarding its results for the quarter ended March 31, 2025 . Key Highlights and Developments This profitability inflection point achievement follows a period of rapid and decisive operational restructuring, during which Trinity Biotech consolidated and offshored its manufacturing and corporate services to significantly reduce its cost base. These strategic moves have laid the groundwork for a leaner, more agile organization capable of delivering sustainable profitability. Wit

0 · Reply

hardrock2112 Jun. 30 at 8:01 PM

$TRIB good close, but we really need a close at or above 37 to start the move back to 40

1 · Reply

Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround

Jun 24, 2025, 8:00 AM EDT - 13 days ago

Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation

May 15, 2025, 4:00 PM EDT - 7 weeks ago

Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update

Mar 14, 2025, 4:30 PM EDT - 4 months ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement

Mar 13, 2025, 7:30 AM EDT - 4 months ago

Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process

Feb 28, 2025, 8:30 AM EST - 4 months ago

Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring Technology

Feb 6, 2025, 7:30 AM EST - 5 months ago

Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial

Jan 28, 2025, 7:20 AM EST - 5 months ago

Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology

Dec 24, 2024, 8:33 AM EST - 6 months ago

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

Dec 18, 2024, 11:00 AM EST - 7 months ago

Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV

Nov 15, 2024, 12:37 PM EST - 8 months ago

Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript

Nov 15, 2024, 9:00 AM EST - 8 months ago

Trinity Biotech Announces Q3 2024 Financial Results

Nov 14, 2024, 8:07 AM EST - 8 months ago

Trinity Biotech to Announce Q3 2024 Financial Results

Nov 7, 2024, 8:19 AM EST - 8 months ago

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

Oct 25, 2024, 8:45 AM EDT - 9 months ago

Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

Oct 25, 2024, 8:45 AM EDT - 9 months ago

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

Oct 7, 2024, 8:15 AM EDT - 9 months ago

Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology

Sep 24, 2024, 4:05 PM EDT - 10 months ago

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

Sep 18, 2024, 4:05 PM EDT - 10 months ago

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

Sep 9, 2024, 4:05 PM EDT - 10 months ago

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

Sep 3, 2024, 9:55 AM EDT - 10 months ago

Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer

Aug 26, 2024, 4:05 PM EDT - 11 months ago

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

Aug 20, 2024, 5:00 PM EDT - 11 months ago

Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director

Aug 16, 2024, 3:43 AM EDT - 11 months ago

Trinity Biotech plc (TRIB) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 7:30 AM EDT - 11 months ago

Trinity Biotech Announces Q2 2024 Financial Results

Aug 13, 2024, 4:05 PM EDT - 11 months ago

Trinity Biotech to Announce Q2 2024 Financial Results

Aug 6, 2024, 4:05 PM EDT - 11 months ago

Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements

Aug 2, 2024, 9:24 AM EDT - 1 year ago

Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience

Jul 9, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech Announces Appointment of A New CFO

Jun 24, 2024, 7:00 AM EDT - 1 year ago

Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor

Jun 10, 2024, 9:10 AM EDT - 1 year ago

Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association

Jun 3, 2024, 4:00 AM EDT - 1 year ago

Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology

May 23, 2024, 6:44 PM EDT - 1 year ago

Trinity Biotech plc (TRIB) Q1 2024 Earnings Call Transcript

May 23, 2024, 8:00 AM EDT - 1 year ago

Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance

May 21, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech plc to Announce Q1 2024 Financial Results

May 16, 2024, 9:18 AM EDT - 1 year ago

Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI

May 13, 2024, 11:42 AM EDT - 1 year ago

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales

May 8, 2024, 10:36 AM EDT - 1 year ago

Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development

Apr 4, 2024, 3:03 PM EDT - 1 year ago

Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript

Apr 4, 2024, 7:30 AM EDT - 1 year ago

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

Mar 28, 2024, 6:39 PM EDT - 1 year ago

Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

Mar 8, 2024, 10:03 AM EST - 1 year ago

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Feb 15, 2024, 12:34 PM EST - 1 year ago

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

Feb 13, 2024, 9:00 AM EST - 1 year ago

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

Feb 8, 2024, 8:30 AM EST - 1 year ago

Trinity Biotech to Present at Emerging Growth Conference

Feb 7, 2024, 8:30 AM EST - 1 year ago

Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

Jan 31, 2024, 5:14 PM EST - 1 year ago

Trinity Biotech plc (TRIB) Acquisition of the CGM Assets of Waveform Technologies and Q3 2023 Earnings Call (Transcript)

Jan 31, 2024, 7:05 AM EST - 1 year ago

Trinity Biotech Announces Q3 2023 Financial Results & Business Update

Jan 31, 2024, 7:02 AM EST - 1 year ago

Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India

Jan 31, 2024, 7:00 AM EST - 1 year ago

Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.

God_Damnit Jul. 6 at 9:23 PM

0 · Reply

GuineaPigForever Jul. 3 at 10:49 AM

1 · Reply

GuineaPigForever Jul. 2 at 8:05 PM

$TRIB short volume (not to be confused by short interest) was over 50% the last couple of days and likely today too. Over half of all trades were shorting.

0 · Reply

GuineaPigForever Jul. 2 at 7:49 PM

$TRIB yep, par for the coarse for a bio stock after a couple rounds of good news. Nothing fishy here.

0 · Reply

GuineaPigForever Jul. 2 at 2:48 PM

$TRIB looks like they borrowed over 40,000 shares just a few minutes ago. Wonder why they see a short position is wise here?

0 · Reply

RollingDollars Jul. 2 at 9:42 AM

$TRIB

0 · Reply

Benamin38659 Jul. 2 at 8:49 AM

$TRIB quarter revenue of 7.6 million.

0 · Reply

Super5Investments Jul. 2 at 2:20 AM

$TRIB Investment community hates this stock. Its a natural born loser.Even good news like profitability cant move it.

0 · Reply

hardrock2112 Jul. 1 at 1:19 PM

0 · Reply

hardrock2112 Jun. 30 at 8:01 PM

$TRIB good close, but we really need a close at or above 37 to start the move back to 40

1 · Reply

elfortune Jun. 30 at 2:36 PM

$TRIB idk what I thinking about that peoples out here don’t know how potential this company have, this should be over 1$ ez with the news. Still happy that I am early and everything.. But it’s weird…

0 · Reply

GuineaPigForever Jun. 30 at 1:36 PM

$TRIB They sure do play games with this on low volume and big spreads. This is a long hold for me with positive stuff happening. There may be a big pump before an offering. Then boom...down she goes for a while. Its like pharma clockwork.

0 · Reply

Benamin38659 Jun. 27 at 7:26 PM

$TRIB all You Have to do is take down 0.78 and you will be rewarded

0 · Reply

Benamin38659 Jun. 27 at 7:11 PM

$TRIB wall At .78 and we off

0 · Reply

elfortune Jun. 27 at 3:04 PM

$TRIB there she goes Don’t understand how she isn’t above 1$ with such a good news When she will across it.. oh boy GL to the 🩳

0 · Reply

RollingDollars Jun. 27 at 2:52 PM

$TRIB .

0 · Reply

Benamin38659 Jun. 27 at 2:32 PM

$TRIB

0 · Reply

m1ster_leboeuf Jun. 27 at 8:15 AM

$TRIB It seems they can do whatever they want - short push and bus crash again and again and again… holy hell.

0 · Reply

Think_Bigly Jun. 26 at 7:52 PM

$TRIB FAFO

0 · Reply

Raider10 Jun. 26 at 5:44 PM

$TRIB holy hell. What happened here? Glad I sold 😬

0 · Reply

Baazigar30 Jun. 26 at 4:23 PM

$PSTV U.S. commercial rollout of novel diagnostic platform to begin second half 2025 Underserved CNS cancer diagnostic U.S. market opportunity estimated to be in excess of $6 billion $TRIB announced it has received World Health Organization (WHO) approval for the offshored and outsourced upstream manufacturing activities of its high-volume TrinScreen™ HIV rapid test, a cornerstone diagnostic product used in HIV screening program IMO two solid stocks for huge upside potential

1 · Reply

BrenWest Jun. 26 at 1:41 PM

$TRIB

0 · Reply

Market Cap	13.54M
Revenue (ttm)	61.56M
Net Income (ttm)	-31.79M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-51.64%
Debt to Equity Ratio	-2.06

Volume	107,800
Avg Vol	1,006,290
Day's Range	N/A - N/A
Shares Out	18.05M
Stochastic %K	51%
Beta	0.80
Analysts	Strong Buy
Price Target	$15.00